Sri Mulyani Frees PNPB Of Antigen Test Validation

ILLUSTRATION/UNSPLASH

JAKARTA - Minister of Finance Sri Mulyani Indrawati waives the rate of Non-Tax State Revenue (PNBP) on the validity of the Antigen Rapid Diagnostic Test conducted by a laboratory within the Ministry of Health.

This provision is issued through the issuance of the Minister of Finance Regulation number 104/PMK.02/2021 concerning Tariffs on Types of Non-Tax State Revenue (PNBP) for Antigen Rapid Diagnostic Test Validity Test Services at the Ministry of Health.

"The PNBP rate for testing the validity of the Rapid Diagnostic Test Antigen as referred to in Article 1 can be set to Rp0.00 or zero rupiah or 0 percent," said the Ministry of Finance's official statement quoted by Antara, Saturday, August 14.

The validity test of the Rapid Diagnostic Test Antigen carried out by a laboratory within the Ministry of Health with this regulation is subject to a tariff of Rp694 thousand per test.

Validity test of the Rapid Diagnostic Test Antigen is a service of a series of tests by a laboratory appointed by the Minister of Health to determine the validity of the Rapid Test Antigen in accordance with established standards.

The Minister of Health through Decree Number 477 of 2021 concerning the Testing Laboratory for the Validity of the Antigen Rapid Diagnostic Test appointed several testing laboratories, including laboratories within the scope of the Ministry of Health.

This laboratory appointed by the Minister of Health has the task of testing the basic ingredients or reagents owned by the company before the Rapid Diagnostic Test Antigen product can be circulated.

The procedure for testing the validity of the Rapid Diagnostic Test Antigen is regulated in the Decree of the Minister of Health, including the provisions on the amount, procedure, and requirements which are also regulated in the Regulation of the Minister of Health.

For information, the Rapid Diagnostic Test Antigen validity test service is different from the antigen test service provided by the antigen test service provider to the public.

The highest tariff for antigen test services has been regulated through the Circular Letter of the Director-General of Health Services number HK.02.02/1/4611/2020.